Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Canadian Liver Journal|July 6, 2026
Co-creating discovery in basic science: Challenges and opportunities in patient-partnered research for rare liver diseaseDiana Nakib, Mary Vyas, Rachel Gomel, et al.Clinical Science (London, England : 1979)|October 28, 2021
The immune niche of the liverMichael L Cheng, Diana Nakib, Catia T Perciani, et al.Histopathology|July 25, 2023
Analysis of various ATP-binding cassette transporters revealed quantification of ABCB4 as a potential diagnostic tool in primary sclerosing cholangitis (PSC)Cornelia Thoeni, Catia T Perciani, Diana Nakib, et al.Scientific Data|June 24, 2026
High-resolution spatial transcriptomics of adult and pediatric human liver with Visium HDFaizan Hasan, Rachel D Edgar, Jawairia Atif, et al.Biorxiv : the Preprint Server for Biology|June 4, 2026
Cholangiocyte RUNX1 Orchestrates Fibrogenic and Inflammatory Signaling to Drive Biliary FibrosisSayed Obaidullah Aseem, Jing Wang, Ahmed Younis, et al.Hepatology Communications|October 7, 2025
Single-cell atlas of human pediatric liver reveals age-related hepatic gene signaturesRachel D Edgar, Diana Nakib, Damra Camat, et al.Cellular and Molecular Gastroenterology and Hepatology|September 4, 2025
IL-4-mediated Pro-Regenerative Cellular Reprogramming in 3D Liver CultureDamra Camat, Diana Nakib, Sai W Chung, et al.Journal of Hepatology|January 10, 2024
Single-cell, single-nucleus, and spatial transcriptomics characterization of the immunological landscape in the healthy and PSC human liverTallulah S Andrews, Diana Nakib, Catia T Perciani, et al.Nature|November 25, 2021
FAM72A antagonizes UNG2 to promote mutagenic repair during antibody maturationYuqing Feng, Conglei Li, Jessica A Stewart, et al.Journal of Hepatology|August 22, 2025
Claudin-1 is a mediator and therapeutic target in primary sclerosing cholangitisFabio Del Zompo, Emilie Crouchet, Tessa Ostyn, et al.Pageof 1